Canadian CRO KGK signs pact with health screening provider Predictmedix
15 Feb 2024
Acquisition
Preview
Source: FierceBiotech
KGK Science, which is based in London, Ontario, was acquired by Auxly Cannabis Group in 2018 in a cash and stock deal valued at $12.3 million.
KGK Science, a Canadian CRO focused on health and wellness, signed a partnership with Predictmedix AI, which provides health screening and remote patient care solutions.
The deal meshes Predictmedix’s health assessment technologies with KGK’s clinical research and regulatory experience with the goal of making “transformative changes in healthcare innovation,” the company said in a Feb. 12 press release. The two companies will work together on patient screening, health data collection accuracy and continuous monitoring.
Financial terms of the agreement weren't disclosed.
KGK, which is based in London, Ontario, was acquired by Auxly Cannabis Group in 2018 in a cash and stock deal valued at $12.3 million.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.